Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Texas DWI Defense Attorney Carl David Ceder Awarded ACS-CHAL Forensic Lawyer Scientist Designation by the American Chemical Society and Axion Laboratories
  • USA - English


News provided by

Ceder Law Firm

Dec 13, 2017, 04:00 ET

Share this article

Share toX

Share this article

Share toX


PLANO, Texas (PRWEB) December 13, 2017 -- Texas DWI Defense Attorney Carl David Ceder completed the required courses for the American Chemical Society-Chemistry and the Law Division: Forensic Lawyer Scientist Designation at: Axion Laboratories, Inc. in Chicago, IL. To read more about this accomplishment, please read here: http://www.forensicchromatography.com/acs-chal-forensic-lawyer-scientist-carl-david-ceder-from-texas/.

It is known, both inside and outside of the ACS, the instructors of these courses wanted to recognize the accomplishment and time commitment of the attorneys who truly learn and understand forensic science as it relates to the law.

Post this

After completing all four required courses, Texas DWI Defense Attorney Carl David Ceder had to pass a rigorous written examination to be eligible for the ACS-CHAL Forensic Lawyer-Scientist Designation. There are currently less than 100 attorneys nationwide that have completed and received the ACS-CHAL Forensic Lawyer-Scientist Designation.

Carl obtained certificates from Axion Laboratories Forensic Chromatography: Theory & Practice (2015, 2017), Forensic Analysis of Solid Drugs (2017) and Forensic Principles of DUID (2017) with coursework and training through Axion Analytical Labs, Inc.

Like “poet-warrior” or “philosopher-king,” there are lawyers of a new breed known as the ACS-CHAL Forensic Lawyer-Scientist. The ACS-CHAL Forensic Lawyer-Scientist is one who uses validated and legitimate science for the benefit of justice. These are lawyers who study the science and apply it legitimately in the courtroom. They expose invalid or non-validated science and use valid science in the courtroom. They eschew the smoke and mirrors techniques of old and embrace the science for the benefit of all. More details on ACS-CHAL Forensic Lawyer – Scientist can be found at: http://www.forensicchromatography.com/.

What is a Forensic-Lawyer-Scientist?
A lawyer-scientist is an attorney with a strong understanding of forensics, chromatography, toxicology, and other related fields, and utilizes this knowledge for the legitimate use in the court of law to best benefit justice. In plain English, this means that your lawyer knows just as much as the science behind the laws as the State’s experts who work in forensic laboratories and testify in criminal trials.

The official title is “The ACS Forensic Lawyer-Scientist Designation as recognized by the Chemistry and the Law Division of the ACS” but ACS-CHAL has approved a shorthand where the person who has earned the honor can say that he or she has earned “The ACS-CHAL Forensic Lawyer-Scientist.

The ACS-CHAL Lawyer-scientist is a highly exclusive designation (less than 100 total in the entire nation) given out by the Chemistry and Law Division of the American Chemical Society. In addition to their own independent studies, lawyer-scientists have to pass a series of forensic courses, pass a proficiency examination, maintain strong standing with the bar association and remain an active member of the ACS-Chemistry and the Law Division so that they can stay up to date on the latest scientific advances.

Description of the Program:
With more than 161,000 members, the American Chemical Society (ACS) is the world’s largest scientific society and one of the world’s leading sources of authoritative scientific information. The Chemistry and the Law Division (CHAL) has over 1400 members. A nonprofit organization, chartered by Congress, ACS is at the forefront of the evolving worldwide chemical enterprise and the premier professional home for chemists, chemical engineers and related professions around the globe.

The American Chemical Society sponsors and approves the "Forensic Lawyer-Scientist" designation offered for lawyers through Axion Analytical Labs in Chicago, IL. The ACS Education Committee has previously approved all 3 courses. Details on the 3 classes can be found here: http://www.forensicchromatography.com/.

1.    The first class (has to be taken twice) “Forensic Chromatography” involves DUI ethanol based analysis by HS-GC-FID. The first and second courses: “Introduction to Forensic Chromatography” focused on ethanol analysis using Head Space Gas Chromatography with a Flame Ionization Detector. This is the process used by most government crime labs in analyzing a driver’s blood sample to try to convict someone of driving under the influence. “Advanced Forensic Chromatography” focuses on the most advanced topics related to Head Space Gas Chromatography, including troubleshooting problems that arise in the chromatography process.

2.    The second class “Forensic Drug Analysis” involves the instrumental analysis of solid drugs in their pre-consumption form using FTIR, GC-MS, Colormetrics, Microscopy, Thin Layer Chromatography, etc. The course teaches participants to understand how drug testing in pre-consumption form (solid drug dose) is conducted for nearly all drugs of abuse, sources of uncertainty (misidentification) of the qualitative measure, sources of uncertainty (wrong concentration or weight) of the quantitative measure, representative sampling, validation of methods, bench work, and federal analog act prosecution. Attendees used reagents (colorimetric analysis), GC-MS, GC-FID, and FTIR instruments with samples containing unknowns.

3.    The third class “Forensic Principles of DUID” involves the pharmacology of drugs, also driving issues in drugs, as well as instrumental analysis using GC-MS. It primarily focuses on the analysis of biological fluids (blood, urine, hair, oral fluid) for drugs of abuse. As the name implies, it focuses on DUID from the alleged motorist’s point of view. The course included instrumental analysis on the qualitative and quantitative analysis, in addition to pharmacology including pharmacokinetics and pharmacodynamics. The course involved hands-on use of instruments and actual processing of biological samples.

All three classes are hands-on classes with labs and actual sample development, testing, and data interpretation. We use the instruments, in the same way, using the same matrices in the Axion Laboratory as an analyst would in a forensic laboratory. They are wonderfully educational and wholly unique.

It is known, both inside and outside of the ACS, the instructors of these courses wanted to recognize the accomplishment and time commitment of the attorneys who truly learn and understand forensic science as it relates to the law. To obtain this designation, it is something beyond simply an attendance based achievement, but also recognized retention of the highly specialized knowledge.

Eligibility for Forensic Lawyer-Scientist Designation:
To earn an ACS Forensic Lawyer-Scientist Designation as recognized by the Chemistry and the Law Division of the ACS, the prospects must complete coursework outlined below and then take and pass a proficiency test based upon what is learned in those courses. The official qualification criteria are as follows:
1.    You must be and remain a member in good standing with the ACS-Chemistry and the Law Division.
2.    You must be a lawyer in good standing with your state bar.
3.    You must answer questions put to you by CHAL about your bar status upon demand as well as your compliance with all terms and conditions of the designation.
4.    You must successfully complete the ACS Forensic Chromatography Course TWO TIMES.
5.    You must successfully complete the ACS Solid Drug Dose (Forensic Drug Analysis) Course.
6.    You must successfully complete the ACS Forensic DUID (Forensic Principles of DUID) Course.
7.    You must pass a proficiency and knowledge examination based upon the courses.
8.    You must agree that the advertising and display of any credentials will be done only in a tasteful and ethical manner per the ACS and your state bar rules and per the language of “ACS Forensic Lawyer-Scientist Designation as recognized by the Chemistry and the Law Division of the ACS” or shortened simply to having earned “The ACS-CHAL Forensic Lawyer-Scientist Designation” or referring to the person as an “ACS-CHAL Forensic Lawyer-Scientist.”
9.    You must agree that that these rules and terms may change without future notice or right to appeal.

For more information about Texas DWI Defense Attorney Carl David Ceder and his legal services, you can contact him at 214.702.CARL(2275) or visit: http://www.TexasDWIDefender.com.

Carl Ceder, Ceder Law Firm, http://www.DFWDefender.com, +1 214.300.5262, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.